State governor says UAB’s precision medicine center will ‘stimulate major strides in science and medicine and serve as a wise investment with a great return.’
Precision Medicine Models
The adoption of a precision medicine program by such a large insurer is expected to significantly expand the availability of precision medicine options within the state.
Because of the increased number of risk adjustment programs, improved diagnosis and treatment of chronic kidney disease (CKD) could trigger substantial financial benefit. This research maps a path for physicians and health systems to better utilize existing medications for their patients with CKD.
Two distinct entities will be created. The capabilities of the new US-Isaeli international partnership model are predicted to be a boon for oncologists and cancer therapeutics developers. It aims to untangle “medical mysteries in patients …”
Although Genomic Testing Cooperative’s agreement with New Jersey-based Hackensack Meridian Health is in its early stages, what is learned from the unique co-op model agreement will be useful for hospital and health system leaders who are evaluating precision medicine approaches.